Circulating antiplasmin-cleaving enzyme (APCE) has a role in fibrinolysis and appears structurally similar to fibroblast activation protein (FAP), a cell-surface proteinase that promotes invasiveness of certain epithelial cancers. To explore this potential relationship, we performed comparative structure/function analyses of the two enzymes. APCE from human plasma and recombinant FAP (rFAP) exhibited identical pH optima of 7.5, extinction coefficients ( 
INTRODUCTION
Human 2 -antiplasmin ( 2 AP) becomes rapidly crosslinked to fibrin by activated clotting factor XIII (FXIIIa) and protects fibrin by rapidly inhibiting plasmin within the fibrin clot 1, 2 . Fibrin containing reduced 2 AP activity is susceptible to fibrinolysis, while fibrin containing a normal amount of 2 AP is strikingly resistant to lysis by plasmin [2] [3] [4] [5] [6] . Human 2 AP was thought to have an N-terminal Asn and a 39-residue signal peptide until later work demonstrated that 2 AP was secreted from liver cells as a 464-residue protein with an additional 12 residues at the N-terminus (Met-2 AP), making the signal peptide 27 residues [7] [8] [9] [10] . The N-terminal 12-residue peptide of Met-2 AP was reported to be cleaved in the circulation by an unknown proteinase 10 . In normal human plasma, the ratio of Met-2 AP to Asn-2 AP was estimated as ~30:70% 9, 10 . We showed that during clot formation Asn-2 AP becomes crosslinked to fibrin by FXIIIa ~13X faster than Met-2 AP, and as a consequence, clot lysis rates slow in direct proportion to the ratio of Asn-2 AP/Met-2 AP in human plasma 5 .
We purified the plasma proteinase that converts Met-2 AP to Asn-2 AP, and termed it antiplasmin-cleaving enzyme (APCE) 5 . Its N-terminal amino acid sequence corresponded to residues 24-38 of fibroblast activation protein (FAP), also known as seprase, a type II integral membrane glycoprotein, which is predicted to have its first six N-terminal residues within the fibroblast cytoplasm, followed by a 20-residue transmembrane domain, and then a 734-residue extracellular C-terminal catalytic domain 5, 11, 12 . FAP is a proline-specific enzyme that exhibits gelatinase activity as well as dipeptidyl peptidase activity 13 .
FAP and
For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From dipeptidyl peptidase IV (DPP IV), which is another post-prolyl peptidase, are members of the S9b peptidase family in which the order of Ser/Asp/His in the active-site is different from that in the chymotrypsin-like serine proteinase family 14 . FAP is reported to be expressed by fibroblasts of reactive stroma of epithelial-derived cancers, but not by counterpart normal tissues 13, 15, 16 . Subsequent studies showed that FAP is also expressed by several types of neoplastic parenchymal cancer cells and also by endothelial cells of newly formed vessels within certain neoplasms [17] [18] [19] [20] [21] . In a murine breast cancer model, cells transfected to express FAP form more rapidly growing tumors when compared to controltransfectants 22 . While these findings suggest that FAP may be a potential target for diagnostic and therapeutic approaches in certain cancers 23 , its biologic function remains unknown. To date no certain physiologic substrate for FAP has been identified. Schmidt et al. 24 indicated that no detectable soluble FAP, or a derivative of such, could be found in human blood; however, our finding of APCE in human plasma 5 is inconsistent with this. Interestingly, Collins et al. 25 have found FAP-like activity in bovine serum which is in accord with our report of APCE in human plasma. APCE may be a soluble, circulating derivative of FAP, resulting from cleavage of the Cys23-Ile24 bond in the transmembrane or extracellular domain of FAP, and if so, its presence in plasma could impact the use of therapeutic agents designed to target FAP at the tissue level 23, 24 . We now report direct evidence that the two proteins are essentially identical.
We obtained sufficient quantities of APCE from human plasma and soluble human rFAP from a yeast expression system to allow determinations and comparisons of previously unreported molecular structure/function details for the two proteinases.
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MATERIALS AND METHODS

Materials
Human plasma Met-2 AP was isolated from a mixture of Met-2 AP and Asn-2 AP using Met-2 AP-specific antibody as previously described 5 ; a percent extinction coefficient of 2 AP at 280 nm of 6.70 and a molecular weight of 70,000 were used to determine molar concentration 26 . Hybridoma cells secreting the F19 monoclonal antibody to FAP were purchased from American Type Culture Collection (Manassas, VA) and grown in serumfree media; the F19 antibody was purified from hybridoma cell culture media using MEP-Hypercel chromatography (Pall Corp., East Hills, NY). An EST cDNA clone (GenBank accession #: AV698972) was obtained from Dr. Ze-Guan Han, through the Chinese National Human Genome Center at Shanghai, China. Upon determining its sequence, using M13-forward and M13-reverse primers in conjunction with four specific primers, the EST clone was shown to contain full-length FAP cDNA (GenBank accession #: NM_004460). Other reagents included: Pichia pastoris expression vector pPICZ A
and Pichia pastoris X-33 (Invitrogen, San Diego, CA), TPCK-treated trypsin (Sigma, St.
Louis, MO), and Z-Gly-Pro-AMC and Ala-Pro-AFC (Bachem, Torrance, CA). AMC (7- amido-4-methylcoumarin) and AFC (7-amino-4-trifluoromethylcoumarin) were obtained from MP Biochemicals (Aurora, OH). A fluorescence resonance energy transfer (FRET)
peptide, Arg-Lys(DABCYL)-Thr-Ser-Gly-Pro-Asn-Gln-Glu-Gln-Glu(EDANS)-Arg was synthesized in-house as previously described 5 . Asn-Gln-Glu-Gln-Glu(EDANS)-Arg was
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Isolation of APCE
APCE was partially purified by ammonium sulfate precipitation and hydrophobic interaction chromatography as previously described 5 . The activity peak was applied to an immunoaffinity column made with F19 monoclonal antibody and eluted with 5 M LiCl.
Based on Z-Gly-Pro-AMC cleaving activity, the active fractions were pooled and brought to 6% ammonium sulfate, applied to a Phenyl-5PW column (Tosohaas, Montgomeryville, PA) equilibrated in 6% ammonium sulfate, and eluted with 12.5 mM sodium phosphate, pH 7.5. Before storing at -80 °C, glycerol was added to purified APCE to give a final concentration of 20%.
Construction of rFAP Expression Vector and Transformation of Pichia pastoris
Human FAP cDNA with XhoI and NotI sites at the 5' and 3' ends, respectively, was 
Expression and Purification of Recombinant FAP
Zeocin resistants (100 colonies) were screened by determining rFAP activity in expression culture medium. Five ml cultures were grown overnight in BMGY medium (buffered glycerol complex medium) at 29°C and cells were harvested by centrifugation at 2000 x g.
Cell pellets were resuspended with 5 ml BMMY medium (BMGY with 5 ml of methanol per liter in place of glycerol), and then induction was continued with fresh methanol (5 ml per liter) added every 24 hours for 3 days. Z-Gly-Pro-AMC cleaving activity in the culture medium was monitored.
The yeast cells displaying highest activity were grown to A 600 of 2-3 in 200 ml of BMGY medium in a two-liter baffled flask at 29°C. The cells were harvested and resuspended in 200 ml of BMMY medium and cultured at 29 °C for 5 days and then centrifuged at 12,800 x g for 40 min at 4°C to pellet the yeast cells. The supernatant was filtered through 0.1 µm Millipore membranes to remove solid residuals, and purified by the same procedure as described for APCE. Quantitation was performed by summing all detected isotopes of each peptide.
Size Exclusion Chromatography
RESULTS
Expression and Purification of rFAP
We have suggested that APCE may be the N-terminally-cleaved form of FAP, partially because the N-terminal 15 amino acids of APCE are identical to residues 24-38 of FAP 5 .
Therefore the 23 residues were removed by amplifying the coding region of full-length FAP cDNA between amino acid residues 24 and 760. Using the amplified DNA and
Pichia pastoris vector pPICZ A, the expression vector was constructed for secretion of rFAP into media. Figure 1A shows that purified rFAP or APCE gives a single band of 93 kDa or 97 kDa, repectively, on reduced SDS-PAGE. Identical patterns for both enzymes were also observed in the absence of reducing agent. Figure 1B shows that the F19 monoclonal antibody to FAP 13 cross-reacts with both APCE and rFAP.
Our purification process for rFAP produced ~42 µg of pure protein from one liter of culture media to give a 17% yield. Protein concentration of rFAP or APCE was calculated using percent extinction coefficients of 20.5 or 20.2, respectively, at 280 nm as determined by us. Figure 2 shows the effects of pH on the specific activity of rFAP and APCE. At this time we have no explanation for the wide range of enzyme activity over the pH spectrum examined these studies. For each enzyme, the pH optimum was 7.5 for the cleavage of the Pro-Asn bond in the FRET peptide substrate, Arg-Lys(DABCYL)-Thr-Ser-Gly-Pro-Asn-Gln-Glu-Gln-Glu(EDANS)-Arg. Both enzymes also showed the same pH optima with the substrate Z-Gly-Pro-AMC (data not shown).
Sequence Analysis of rFAP and APCE
The N-terminal amino acid sequences of rFAP and APCE were determined by using an automated protein sequencer. As shown in Figure 3 As shown in Figure 3 , amino acid sequences of peptides obtained from trypsin digests of rFAP and APCE are identical to the sequence derived from FAP cDNA sequence.
Homodimer Formation Required for APCE or rFAP Activity
For
org From FAP appears to be composed of two 97 kDa identical subunits in a homodimeric structure, suggested as necessary for both dipeptidyl peptidase and gelatinase activities 11, 13 .
Definitive data, however, showing that dimerization is required for activity are lacking.
As shown in Figure 4 , we examined this directly using zymography and size exclusion chromatography. When boiled in SDS, APCE and rFAP showed 97 and 93 kDa bands, respectively, and given complete denaturation, no gelatinase activity was observed ( Figure 4A ). However, non-boiled samples, from which SDS was removed by incubating the zymogram-gelatin gel in a renaturing buffer after electrophoresis ( Figure 4A ), clearly showed both 170 kDa and 180 kDa gelatinase activities for APCE and rFAP, respectively.
Also noted were remaining inactive 97 kDa and 93 kDa monomer bands for both enzymes, which despite renaturation efforts, lacked gelatinase activity. The molecular size of APCE was consistent with prior reports of 175 kDa for enzymatically active FAP homodimer and 95 kDa for the inactive monomer 11, 13, 29 . Without SDS in the samples, the gelatinase activity band of rFAP migrated slightly slower than that of APCE, and both band intensities increased ~20-fold compared with non-boiled SDS-containing sample bands; monomeric bands were not apparent ( Figure 4B ). Although by SDS-gel electrophoreses the monomer band of APCE migrates slower than that of rFAP ( Figure   4A ), the dimeric form of APCE migrates faster than that of rFAP in the non-SDS gel ( Figure 4B ). We speculate that this may be due to the negative surface charge of APCE being higher than for rFAP due to differences in glycosylation. Similar size discrepancy has been reported in native and recombinant DPP IV proteins, which are in the same S9b peptidase family as FAP 30 . Using size exclusion chromatography, we also assesssed whether APCE or rFAP remains as an enzymatically active dimer in phosphate-buffered Figure 4C , APCE is present as a 175 kDa protein peak, while rFAP gives a 153 kDa peak. No other peaks are present, particularly in the monomeric 95 kDa range. The rFAP peak showed a broader mass distribution than APCE that is probably due to heterogeneous glycosylation by the yeast-expression system 31 . The broader peak observed for rFAP on size exclusion chromatography is also consistent with the broader band for rFAP by SDS-PAGE when compared to APCE (Figure 1 ). Both the 175 kDa and 153 kDa peak fractions have gelatinase and Ala-Pro-AFC cleaving activities. These data from zymography and size exclusion chromatography suggest that homodimers are required for enzymatic activity and monomers lack such function.
Substrate Specificity of rFAP and APCE
To determine if rFAP has the same specificity as APCE, enzymatic activities of rFAP and APCE were compared using selected synthetic peptides as substrates ( for cleavage of Z-Gly-Pro-AMC, Ala-Pro-AFC, and FRET peptide are essentially the same towards each substrate. However, the k cat /K m value for cleavage of FRET peptide, remembering that it is modeled on the sequence surrounding the APCE-cleavage site (Pro12-Asn13) of Met-2 AP, is ~8-fold higher than for Z-Gly-Pro-AMC and ~12-fold higher than for Ala-Pro-AFC.
Met-2 AP Cleavage by rFAP
Because our kinetic studies and FRET peptide data suggested that rFAP, just as APCE 5 , may specifically cleave Met-2 AP at Pro12-Asn13, rFAP was incubated with Met-2 AP and the mixture examined at selected times by Western blot analysis. As demonstrated in Figure 5A , the intensity of the Met-2 AP band decreased with time when immunoblotted with a specific antibody to the 12-residue N-terminal peptide of Met-2 AP 5 . Figure 5B, however, shows that a blot immunostained with an antibody that detects both N-terminal forms of 2 AP did not change through the entire time course, and bands suggesting fragmentation were never generated. N-terminal analyses of the 0 h sample showed only the Met-2 AP sequence, MEPLGRQLTSGP, while the 7 h sample had only the Asn- 
DISCUSSION
The major goals of this study were (i) to determine if APCE is a soluble form of FAP and
(ii) to systematically characterize the molecular and kinetic properties of both enzymes.
Despite the identity of limited amino acid sequences we previously reported for APCE and FAP 5 , concern remained about differences between the two; namely, FAP has a 23-residue N-terminal extension with Met at the N-terminus, while APCE has Ile as its Nterminus (corresponding to Ile24 in FAP), cleaves Met-2 AP and circulates in blood, unlike what has been reported for FAP 24 . Our initial approach was to develop methods for obtaining sufficient amounts of apparently homogenous APCE from human plasma for characterization. Purification yields of APCE from human plasma were improved fourfold, using a modification of our previous method 5 . To date efforts at structure/function analyses have been limited by low yields of FAP from baculovirus or mammalian cell expression systems and, in addition, by uncertain purity. We chose the Pichia pastoris expression system and found that rFAP was secreted into culture media from which we could obtain ~42 µg of pure rFAP per liter. Pure rFAP, possessing only amino acid
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Our yield of purified protein was ~5-fold greater than that reported for insect cells with recombinant baculovirus expressing the 760-residue full-length protein 32 . Chinese hamster ovary cells expressing full-length FAP provided only trace amounts of recombinant protein 34 .
Based on comparison of APCE and rFAP amino acid sequences to the published sequence for FAP cDNA, we found that APCE and rFAP each contained only the extracellular C-terminal catalytic domain and no N-terminal cytoplasmic or transmembrane domains; although rFAP is N-terminally shorter by 11 amino acids, it has the same specific activity as APCE. In-gel tryptic digestion and then LC/MS/MS analyses were used to characterize peptides from APCE and rFAP. The analyses identified 30
peptides from APCE and 21 from rFAP, equivalent to 48% and 30%, respectively, of the amino acid sequence predicted from FAP cDNA (Figure 3 ). APCE and rFAP were both purified using the F19 monoclonal antibody specific for FAP 35 , and both enzymes were recognized by the same antibody in Western blot analyses ( Figure 1B) . Hence, data comparing amino acid sequences and antibody cross-reactivities support APCE being a soluble derivative of membrane-bound FAP.
We examined whether a homodimeric structure for APCE or rFAP is required for gelatinase and dipeptidyl peptidase activities, using gelatin zymography and size exclusion chromatography. The homodimeric form of rFAP or APCE cleaves gelatin, AlaPro-AFC and Z-Gly-Pro-AMC, whereas monomers of either had no such activities. While
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From previous data suggested that homodimer formation was needed for enzymatic function 11, 13, 29 , this could only be inferred from zymography that could not provide molecular weight data and no size-exclusion chromatography was done; hence, homodimer structure remained uncertain. The recently published crystal structure of FAP showed that the enzymatically active, soluble form of recombinant FAP expressed by a baculovirus system is a homodimer, but whether monomers have enzymatic activity
was not reported 36 . Each subunit comprises two distinct domains, an / -hydrolase domain (residues 27-53 and 493-760) and a beta-propeller domain (54-492) 36 . Based on its crystal structure, a small region of the propeller (residues 232-258) and three regions of the hydrolase domain (residues 651-657, 706-731 and 737-757) can be predicted to participate in the dimerization of FAP. One might speculate that based on this information, homodimers should be separable into monomers by site-directed mutagenesis or peptides that disrupt dimerization so that it could be determined if monomers possess enzymatic activity, but as yet, this has not been done with FAP. Data in the present study, however, suggest that monomers lack enzymatic activity, reinforcing the speculation that if a peptide inhibitor were designed to compete with dimer interface sequences, and thereby prevent dimerization, then it might be possible to abate FAP activity in pathologic conditions such as certain neoplasms 23, 37, 38 .
While our data support that APCE is soluble FAP and that its homodimeric structure appears to be required for activity expression, we also explored whether the enzymes shared substrate specificities. The synthetic substrates, Ala-Pro-AFC and ZGly-Pro-AMC, and the FRET peptide, synthesized to contain P4-P4' residues of MetFor personal use only. on October 28, 2017 . by guest www.bloodjournal.org From a pH 7.5 optimum at which all kinetic analyses were then performed. Enzyme concentrations and k cat values were calculated using the subunit molecular weights and extinction coefficients as we determined for APCE and rFAP. The kinetic parameters for each enzyme were identical within acceptable error, which again supports rFAP and APCE being essentially the same enzyme. FAP has been reported to prefer Ala-Pro-AFC over Lys-Pro-AFC, and Gly-Pro-AFC 13 . Z-Gly-Pro-AMC, essentially representing a tripeptide, has a 2-3x higher affinity for both rFAP and APCE than does Ala-Pro-AFC ( 
